p-Cymene and Rosmarinic Acid Ameliorate TNBS-Induced Intestinal Inflammation Upkeeping ZO-1 and MUC-2: Role of Antioxidant System and Immunomodulation

Int J Mol Sci. 2020 Aug 15;21(16):5870. doi: 10.3390/ijms21165870.

Abstract

p-Cymene (p-C) and rosmarinic acid (RA) are secondary metabolites that are present in medicinal herbs and Mediterranean spices that have promising anti-inflammatory properties. This study aimed to evaluate their intestinal anti-inflammatory activity in the trinitrobenzene sulphonic acid (TNBS)-induced colitis model in rats. p-C and RA (25-200 mg/kg) oral administration reduced the macroscopic lesion score, ulcerative area, intestinal weight/length ratio, and diarrheal index in TNBS-treated animals. Both compounds (200 mg/kg) decreased malondialdehyde (MDA) and myeloperoxidase (MPO), restored glutathione (GSH) levels, and enhanced fluorescence intensity of superoxide dismutase (SOD). They also decreased interleukin (IL)-1β and tumor necrosis factor (TNF)-α, and maintained IL-10 basal levels. Furthermore, they modulated T cell populations (cluster of differentiation (CD)4+, CD8+, or CD3+CD4+CD25+) analyzed from the spleen, mesenteric lymph nodes, and colon samples, and also decreased cyclooxigenase 2 (COX-2), interferon (IFN)-γ, inducible nitric oxide synthase (iNOS), and nuclear transcription factor kappa B subunit p65 (NFκB-p65) mRNA transcription, but only p-C interfered in the suppressor of cytokine signaling 3 (SOCS3) expression in inflamed colons. An increase in gene expression and positive cells immunostained for mucin type 2 (MUC-2) and zonula occludens 1 (ZO-1) was observed. Altogether, these results indicate intestinal anti-inflammatory activity of p-C and RA involving the cytoprotection of the intestinal barrier, maintaining the mucus layer, and preserving communicating junctions, as well as through modulation of the antioxidant and immunomodulatory systems.

Keywords: antioxidant; cytoprotection; immunomodulation; intestinal inflammation; p-cymene; rosmarinic acid.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Cinnamates / pharmacology
  • Cinnamates / therapeutic use*
  • Colitis, Ulcerative / drug therapy*
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism
  • Cymenes / pharmacology
  • Cymenes / therapeutic use*
  • Depsides / pharmacology
  • Depsides / therapeutic use*
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use
  • Interferon-gamma / genetics
  • Interferon-gamma / metabolism
  • Interleukins / genetics
  • Interleukins / metabolism
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / metabolism
  • Mucin-2 / genetics
  • Mucin-2 / metabolism*
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type II / metabolism
  • Rats
  • Rats, Wistar
  • Rosmarinic Acid
  • T-Lymphocytes / metabolism
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism
  • Zonula Occludens-1 Protein / genetics
  • Zonula Occludens-1 Protein / metabolism*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antioxidants
  • Cinnamates
  • Cymenes
  • Depsides
  • Immunologic Factors
  • Interleukins
  • Muc2 protein, rat
  • Mucin-2
  • NF-kappa B
  • Tjp1 protein, rat
  • Tumor Necrosis Factor-alpha
  • Zonula Occludens-1 Protein
  • 4-cymene
  • Interferon-gamma
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2